NAMHC Minutes of the 272nd Meeting
January 29 and January 30, 2024
Department of Health and Human Services
Public Health Service
National Institutes of Health
National Advisory Mental Health Council
Introduction
The National Advisory Mental Health Council (NAMHC) held its 272nd meeting at 12:30 pm, January 29, 2024, via Zoom and National Institutes of Health (NIH) videocast. In accordance with Public Law 92-463, the session was open to the public until approximately 4:15 pm and was preceded by the closed session on January 30, 2024. Joshua Gordon, M.D., Ph.D., Director of the National Institute of Mental Health (NIMH), presided as Chair for both sessions.
Council Members Present
- Edwin (Ted) Abel, III, Ph.D.
- Olusola Ajilore, M.D., Ph.D.
- Rinad Beidas, Ph.D.
- Pamela Collins, M.D., M.P.H.
- Daniel Gillison, Jr.
- Marguerita Lightfoot, Ph.D.
- Angus MacDonald, III, Ph.D.
- Velma McBride Murry, Ph.D.
- Joel Nigg, Ph.D.
- Matthew Nock, Ph.D.
- Jyotishman Pathak, Ph.D.
- Bryan Roth, M.D., Ph.D.
- Laura Scott, Ph.D., M.P.H.
- Joseph Telfair, DrPH, M.P.H.
- Hongkui Zeng, Ph.D.
Council Members Absent
- Patricia Recupero, M.D., J.D.
Department of Veteran Affairs (Ex Officio Member)
- Amy Kilbourne, Ph.D., M.P.H.
Liaison Representative (Ex Officio Member)
- Anita Everett, M.D., DFAPA
Others present at Open Policy Session (Appendix B)
Others present at Closed Grant Review Session (Appendix C)
OPEN PORTION OF THE MEETING
Open Policy Session Call to Order & Opening Remarks, Joshua Gordon, M.D., Ph.D. (NIH Videocast @00:16)
NIMH Director Dr. Joshua Gordon opened the virtual NAMHC meeting and welcomed Council members, NIMH staff, NIH staff, and members of the public. Following a review of virtual meeting etiquette, the Council unanimously passed a motion approving the final Summary Minutes of the September 2023 meeting.
- NIMH Director’s Report, Joshua Gordon, M.D., Ph.D. (NIH Videocast @05:15)
Congressional Interactions
Dr. Gordon briefly reviewed NIMH senior staff participation in several congressional briefings on topics such as youth mental health, including the impacts of social media, and the anticipated renewal of the Autism CARES Act in summer 2024.
Appropriations and Budget Updates
On January 18, 2024, Congress passed a continuing resolution that funded NIH through March 8, 2024. Congress also announced an agreement on fiscal year (FY) 2024 topline funding levels, including $772.7 billion for nondefense programs, and was negotiating funding levels for 12 appropriation bills.
HHS and NIH Updates
HHS awarded more than $103 million to expand access to maternal health care and more than $230 million in grants for suicide prevention and behavioral health care for marginalized communities. In September 2023, the Interagency Autism Coordinating Committee (IACC) released the 2021-2023 Strategic Plan for Autism Research, Services, and Policy , and in December 2023, the IACC published the 2022 IACC Summary of Advances in Autism Research . The NIMH Office of National Autism Coordination issued a request for information to help identify priorities related to co-occurring conditions in autism.
On September 26, 2023, the Director of the National Institute on Minority Health and Health Disparities (NIMHD), Eliseo Pérez-Stable, M.D., designated people with disabilities as a population with health disparities. Dr. Gordon said that NIMH supported this designation and looked forward to working with NIMHD on reducing disparities in this population. On December 14, 2023, President Joe Biden visited the NIH Clinical Center, met with NIH Director Monica Bertagnolli, M.D., and announced a plan to reduce the costs of prescription drugs . On October 25, 2023, First Lady Jill Biden, Ed.D., and Jodie Haydon, the partner of the Prime Minister of Australia, visited NIH and met with National Cancer Institute (NCI) researchers to discuss research collaborations.
Dr. Gordon reviewed NIH leadership transitions, including the appointments of Dr. Bertagnolli as the 17th Director of NIH; W. Kimryn Rathmell, M.D., Ph.D., as the 16th Director of NCI; Lyric Jorgenson, Ph.D., as NIH Associate Director for Science Policy; Tara Schwetz, Ph.D., as NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives; and Katherine Klimczak, M.P.P., as NIH Associate Director for Legislative Policy and Analysis and Director of the NIH Office of Legislative Policy and Analysis.
NIH made 26 awards totaling approximately $171 million over five years under the Community Partnerships to Advance Science for Society (ComPASS) Program , which is supporting interventions targeting social determinants of health, aimed at structural and community levels. On September 29, 2023, the NIH All of Us Research Program partnered with the National Institute on Drug Abuse to host a webinar on how to use the All of Us Researcher Workbench . All of Us also awarded $30 million to establish the Center for Linkage and Acquisition of Data . On September 26, 2023, The Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative launched its third transformative project, the BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS) .
NIMH News to Know
Dr. Gordon described the success of the NIMH 75th Anniversary Kickoff Event and encouraged the community to review the NIMH 75th Anniversary website to learn more about upcoming events and resources. Lisa Bowleg, Ph.D., M.A., received the 2023 James Jackson Memorial Award for her research on social-structural and behavioral factors that impact the mental health of Black men in the United States. The newly established Division of Data Science and Technology will be led by Director Greg Farber, Ph.D., and Deputy Director Ruben Alvarez, Ed.D. Additionally, Gregory Greenwood, Ph.D., M.P.H., was named Deputy Director of the Division of AIDS Research. Dr. Gordon announced the passing of Sean Marrett, Ph.D., who served in the Intramural Research Program’s Functional MRI Facility. He also announced the retirement of Ann Huston, M.P.A., from her position as Deputy Director of Management/Executive Officer, effective February 2024.
Science Highlights
Dr. Gordon shared three science highlights. The first study1 aimed to replicate the NIMH-funded AURORA study, which found that brain-based biotypes could predict the likelihood of developing anxiety and post-traumatic stress disorder (PTSD) in the aftermath of exposure to a traumatic event. The new study did not replicate these findings, emphasizing the need for robust techniques, technologies, and approaches with large datasets to ensure generalizability across populations.
The second study2 looked at a large group of individuals with psychosis in inpatient settings to determine whether an acceptance and commitment therapy intervention could improve adherence to treatment after hospitalization and reduce the risk of re-hospitalization. They found that individuals receiving the intervention did show improvements in the six months after the treatment condition, which was an important finding for treatment in real-world settings.
The third study3 used a rodent model to investigate the role of dynorphin and kappa-opioid receptors in information processing in the medial prefrontal cortex (mPFC). They found that dynorphin can change mPFC activity by regulating the input the mPFC receives from other brain regions. These findings suggest that dynorphin may be a target for treating conditions characterized by dysregulation in the mPFC.
Discussion
Following Dr. Gordon’s update, Council members engaged in a discussion. One Council member asked about where technology development fits with the establishment of DST, and Dr. Gordon clarified that this research will remain within DST’s research portfolio. Council members asked for clarification on the types of research Congress was interested in. Dr. Gordon responded that Congress specifically expressed interest in research on the impact of social media on children and adolescents, as well as research that supports systems-based, public health perspectives. Council members also asked about the impact of the decreased 21st Century Cures Act appropriations. Dr. Gordon noted its potential impact on the BRAIN Initiative. Another Council member asked about the future of the ComPASS program. Dr. Gordon described that the ComPASS program’s first five years are focused on intervention research planning and piloting. ComPASS anticipates funding another five years for full-scale intervention trials, as well as additional funding for another round of awards. Lastly, a Council member asked about how NIMH is involved in the maternal health outcomes initiative, given that many of the efforts are being led by other HHS agencies. Dr. Gordon stated that NIMH staff have been working with other federal agencies to advise on evidence-based mental health practices that will support their efforts as part of this initiative.
Introducing the Advanced Research Projects Agency for Health (ARPA-H), Susan Monarez, Ph.D., Deputy Director, ARPA-H, (NIH Videocast @55:01)
Dr. Gordon facilitated a question-and-answer session with Dr. Monarez.
Question: What is the mission of ARPA-H and what has it accomplished in its first 18 months?
Answer: ARPA-H invests in projects that are high-risk, high-reward across the health ecosystem rather than projects that create incremental improvements. While ARPA-H’s first six months were focused on developing operations and processes, ARPA-H had since executed more than $1 billion in funding across several initiatives, such as cancer diagnostics and treatment, mobile health units that can adapt to the unique needs of rural areas, and alternatives to organ transplants. ARPA-H aims to navigate between traditional knowledge building processes and innovative and accelerated processes that have a direct impact on patients. Data interoperability was one priority area that they would like to see accelerated into near real-time diagnostics and clinical next steps.
Question: How does ARPA-H work with NIH?
Answer: ARPA-H regularly communicates with NIH institutes and centers to ensure that their projects were complementary to and built from knowledge from the NIH portfolio. They also conduct extensive stakeholder outreach to ensure that they understand gaps from patient and provider perspectives. This helps ensure that any disruptive high-risk, high-reward approach is conducted with expert guidance. Another potential interaction between ARPA-H and NIH is data integration and interoperability. NIH holds robust repositories of data that can be translated into knowledge and have the potential to accelerate programmatic decision-making, design, and outcomes. ARPA-H also aims to ensure that data generated from their investments are publicly available. Dr. Monarez emphasized the importance of balancing the tension between data that required further validation to be meaningful and data that is not held back from supporting accelerated innovation.
Question: How does ARPA-H identify its topics of interest?
Answer: ARPA-H utilizes a program manager-centric model in which an individual can propose a program representing a major gap and a unique approach not already supported by other funding mechanisms. ARPA-H evaluates potential program managers carefully, then provides them with a budget over three years to execute their vision. ARPA-H also has a more traditional open solicitation for ideas that come from their external stakeholders. Dr. Monarez noted that ARPA-H does not currently have a program manager in behavioral health. Although there have been several behavioral health proposals, none have yet represented the type of program they would like to fund. There are a number of behavioral health challenges, such as the need for meaningful diagnostic categories, that ARPA-H would like to address.
Question: Does ARPA-H support implementation science?
Answer: ARPA-H is not in a position to support implementation science within their current portfolio, but hope to in the future.
NIMH Special Council Review Policy Update, Susan Koester, Ph.D., Deputy Director, Division of Neuroscience and Basic Behavioral Science (NIH Videocast @01:39:05)
Dr. Koester reviewed the history of Special Council Review (SCR), which was implemented to more effectively manage resources. In 2022, NIMH revised SCR criteria for applications from very well-funded investigators. In 2023, Dr. Gordon challenged NIMH staff to consider whether there could be a more effective distribution of NIMH resources. NIMH formed an internal SCR committee to examine the impact of the current SCR criteria on the NIMH funding portfolio and proposed two revisions to the criteria. First, the committee felt that an “exceptional” score alone was not adequate justification for recommending additional funding and should only be considered when coupled with an application in a high priority research area. Second, the committee suggested revising the criteria for all principal investigators in the application to meet a $2 million threshold to any principal investigator. NIMH planned to issue a revised notice to clarify these changes. Dr. Gordon asked Council for feedback.
Discussion
Council members discussed concerns about junior investigators inadvertently losing their Early Stage Investigator (ESI) status when joining a Multiple Principal Investigators (MPI) application, the potential for a power imbalance, and the need to understand whether junior investigators who were part of an MPI grant eventually moved forward with their own funding. The Council unanimously passed a motion approving the two recommendations for revised SCR criteria.- Concept Clearances (NIH Videocast @02:00:30)
Establishing Standards for Data and Metadata from Wearable Devices, Gregory Farber, Ph.D., Division of Data Science and Technology
Dr. Farber talked about how quantitative data from wearable devices has the potential to provide information relevant to biomarkers of various diagnostic groups related to mental illness. However, there is a need for meaningful data standards and metadata to allow investigators to reuse data and make those data useful for analyses. This concept would support the development of initial data standards as well as further refinement as technology evolved.
Discussion
Discussants: Matthew Nock, Ph.D., and Rinad Beidas, Ph.D.
Drs. Nock and Beidas expressed support for this concept and suggested that there be a range of interested parties (specifically end users) included in the creation of standards, as well as consideration for how to manage personally identifiable data and open data archives. Other Council members underscored the need to consider privacy, ethics, transparency, and public trust, as well as the need for strong academic-industry partnerships and device agnostic standards.Multimodal Artificial Intelligence: Opportunities and Challenges for HIV Clinical Care, Lori Scott-Sheldon, Ph.D., Division of AIDS Research
Dr. Scott-Sheldon explained that the aim of this concept is to strengthen the development, adaptation, and use of accurate, safe, efficient, and unbiased artificial intelligence (AI) models to accelerate HIV diagnosis, prevention, and treatment. Cutting edge multimodal AI models have the potential to augment existing AI and machine learning approaches used in clinical care and promote targeted interventions.
Discussion
Discussants: Joseph Telfair, DrPH, M.P.H., and Jyotishman Pathak, Ph.D.
Drs. Telfair and Pathak expressed support for this concept and commented on the need to define the term “multimodal,” proactively address potential misinformation about AI, consider privacy and security, and adopt ongoing feedback loops to assess models. Other Council members agreed that this concept should be human centered and suggested that implementation science was an important component to integrate. There were suggestions to measure uptake across various interested parties, consider the implementation burden on clinicians, and collaborate with industry to improve feasibility and uptake.Role of T Cells in HIV Central Nervous System Reservoir Seeding, Persistence, and Neuropathogenesis, Jeymohan Joseph, Ph.D., Division of AIDS Research
Dr. Joseph described growing evidence that CD4+ T cells may be critical for HIV entry into the central nervous system (CNS). The aim of this concept is to define the mechanisms underlying the contribution of T cells to CNS reservoir seeding and neuropathogenesis using state-of-the-art methodologies, animal models, postmortem studies, and other novel immunologic approaches, as well as well as strategies to target CNS comorbidities.
Discussion
Discussants: Pamela Collins, M.D., M.P.H., and Olusola Ajilore, M.D., Ph.D
Drs. Collins and Ajilore expressed support for this concept and suggested prioritizing the use of postmortem human tissue given the urgent need to better understand CNS neurotoxicity, particularly among the aging HIV population. Other Council members suggested population-level approaches to potentially identify uniform classification or characterize the extent that T cells impact the CNS.
Comments from Retiring Members, Joseph Telfair, DrPH, M.P.H.; Hongkui Zeng, Ph.D. (NIH Videocast @02:59:44)
Dr. Gordon thanked Dr. Telfair and Hongkui Zeng, Ph.D., for their service to Council and invited them to comment on their experiences. Drs. Telfair and Zeng expressed appreciation for Council’s accomplishments and conveyed their suggestions for the way forward in mental health research.
Adjournment
Refer to Appendix D.
Adjournment
Dr. Gordon adjourned the open session of the meeting at 4:15 pm.
CLOSED PORTION OF THE MEETING
The grant application review portion of the meeting was closed to the public in accordance with provisions as set forth in Section 552b(c)(4) and 552b(c)6. Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended.
Tracy Waldeck, Ph.D., Executive Secretary of the Council, explained policies and procedures regarding confidentiality and conflict of interest to the members of the Council.
Members absented themselves from the meeting during the discussion of and voting on applications from their own institutions, or other applications in which there was a potential conflict of interest, real or apparent. Members were asked to sign a statement to this effect.
| Appendix A DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTE OF MENTAL HEALTH NATIONAL ADVISORY MENTAL HEALTH COUNCIL (Terms end 9/30 of designated year) | |
| CHAIRPERSON Joshua A. Gordon, M.D., Ph.D. Director National Institute of Mental Health Bethesda, MD | EXECUTIVE SECRETARY Tracy Waldeck, Ph.D. Director Division of Extramural Activities National Institute of Mental Health Bethesda, MD |
| Members | |
| Edwin G. Abel, III, Ph.D. (24) Chair and Departmental Executive Officer Department of Neuroscience and Pharmacology Carver College of Medicine University of Iowa Iowa City, IA | Daniel H. Gillison, Jr. (25) Chief Executive Officer National Alliance on Mental Illness Arlington, VA |
| Olusola Ajilore, M.D., Ph.D. (25) Associate Professor Director, Mood, and Anxiety Disorders Program Department of Psychiatry University of Illinois Chicago Chicago, IL | Marguerita A. Lightfoot, Ph.D. (24) Professor Associate Dean for Research OHSU-PSU School of Public Health Portland, OR |
| Rinad S. Beidas, Ph.D. (26) Ralph Seal Paffenberg Professor Chair, Department of Medical Social Sciences Feinberg School of Medicine Northwestern University Chicago, IL | Velma McBride Murry, Ph.D. (25) Lois Autrey Betts Endowed Chair Associate Provost, Office of Research and Innovation University Distinguished Professor Departments of Health Policy & Human and Organizational Development Vanderbilt University Nashville, TN |
| Pamela Y. Collins, M.D., M.P.H, (24) Professor of Psychiatry and Behavioral Sciences Professor of Global Health Schools of Medicine and Public Health University of Washington Seattle, WA | Joel T. Nigg, Ph.D. (24) Professor and Vice Chair for Psychology Director, Center for ADHD Research Department of Psychiatry Oregon Health and Science University Portland, OR |
| Matthew K. Nock, Ph.D. (24) Edgar Pierce Professor of Psychology Harvard College Professor Chair, Department of Psychology Harvard University Cambridge, MA | Laura Scott, M.P.H., Ph.D. (25) Research Professor Department of Biostatics University of Michigan Ann Arbor, MI |
| Jyotishman Pathak, Ph.D. (26) Frances & John L. Loeb Professor of Medical Informatics Department of Population Health Sciences Weill Cornell Medicine Cornell University New York City, NY | Joseph Telfair, Dr.P.H., M.P.H., (23) Professor and Associate Dean for Public Health Practice and Research Karl E. Peace Distinguished Chair of Public Health Fellow, Royal Society of Public Health Jiann-Ping Hsu College of Public Health Georgia Southern University Statesboro, GA |
| Patricia R. Recupero, M.D., J.D. (24) Senior Vice President of Education and Training Care New England Butler Hospital Providence, RI | Hongkui Zeng, Ph.D., (23) Executive Vice President and Director Allen Institute for Brain Science Seattle, WA |
| Bryan L. Roth, M.D., Ph.D. (24) Michael Hooker Distinguished Professor Department of Pharmacology School of Medicine University of North Carolina at Chapel Hill Chapel Hill, NC | |
EX OFFICIO MEMBERS
Office of the Secretary, DHHS
Xavier Becerra, J.D.
Secretary
Department of Health and Human Services
Washington, DC
National Institutes of Health
Lawrence A. Tabak, D.D.S., Ph.D.
Acting Director
National Institutes of Health
Bethesda, MD
Department of Veterans Affairs
Amy M. Kilbourne, Ph.D., M.P.H.
Director, Quality Enhancement Research Initiative (QUERI)
U.S. Department of Veterans Affairs
Professor of Learning Health Sciences
University of Michigan Medical School
Ann Arbor, MI
Liaison Representative
Anita Everett, M.D., DFAPA
Director
Center for Mental Health Services
US, HHS Substance Abuse and Mental Health Services
Rockville, MD
| APPENDIX B Department of Health and Human Services Public Health Service National Institutes of Health National Advisory Mental Health Council Summary of 272nd Meeting, January 29 and 30, 2024 | ||
| Federal Staff Present in Person for Open Policy: | ||
Evon Abisaid Mary Acri Lisa Alberts Susannah Allison Ruben Alvarez Phyllis Ampofo Patricia Areán Paige Anderson Victoria Arango Shelli Avenevoli Frank Avenilla Brian Barnett Anita Bechtholt Andrea Beckel-Mitchener Iddil Bekirov Yvonne Bennett Lora Bingaman Christina Borba Susan Borja Jasenka Borzan Beth Bowers Linda Brady Andrew Breeden Pim Brouwers Sandy Buckingham Marcy Burstein Holly Campbell-Rosen Mindy Chai Sharon Chang Zieta Charles Mark Chavez Eric Choi Serena Chu Jessenia Clary Heather Coulter Didi Cross Leonardo Cubillos Bruce Cuthbert Debra Dabney Beshaun Davis Julius Diggs Jen Donahue Jamie Driscoll Sabiha Ethridge Gregory Farber Jelena Fay-Lukic Katrina Ferrara Beth Finch Craig Fisher Jansen Foster Meredith Fox Mike Freed Stacia Friedman-Hill Nick Gaiano Karen Gavin-Evans | Rebecca Garcia Marjorie Garvey Lisa Gilotty Christopher Gordon Gregory Greenwood Adam Haim Katie Hamill Wanda Harris-Lewis Brittany Haynes Robert Heinssen Lauren Hill Mi Hillefors Shuang-Bao Hu Jennifer Humensky Eliza Jacobs-Brichford Daniel Janes Terri Jarosik Brittany Johnson Andrew W. Jones Jeymohan Joseph Eugene Kane Chris Kees Eunyoung Kim Megan Kinnane Sandeep Kishore Arina Knowlton Susan Koester Charisee Lamar Sarah Leinwand David Leitman Tamara Lewis Johnson Jane Lin Ti Lin Kelly Linthicum Sarah Holly Lisanby Allen Lo Victor Lushin Tianlu Ma Annette Marrero-Oliveras Nicole Martino Julie Mason Kristina Max Juliette McClendon Douglas Meinecke Tatiana Meza-Cervera Enrique Michelotti Nicole Miko David Miller Ashley Moseley Eric Murphy Laurie Nadler Stephen O’Connor Anna E. Ordóñez Nicolette O’Reilly Claudio Ortiz | Christina Page David Panchision Jenni Pacheco Emma Perez-Costas Courtney Pinard Suzy Pollard Amanda Price Vasudev Rao Dianne Rausch Sylvia Reeves Syed Rizvi Mary Rooney Andrew Rossi Laura Rowland Matthew Rudorfer Jonathan Sabbagh Christopher Sarampote Tanisha Savage Aileen Schulte Lori Scott-Sheldon Natasha Sefcovic Teri Senn Pamela Shell Joel Sherrill Lorie Shora Galia Siegel Todd Silber Belinda Sims Ashley Smith Dawn Smith Theresa Smith Abigail Soyombo Anaïs Stenson Michael Stirratt Maggie Sweeney Alexander Talkovsky Julie Thai Laura Thomas Ira Tigner, Jr. Jessica Tilghman Leonardo Tonelli Jing Tran Farris Tuma Justin Valenti Ashlee Van’t Veer Siavash Vaziri Vidya Vedham Aleksandra Vicentic Matthew Vilnit Clarissa B. Vincent Andrea Wijtenburg Kesi Williams Abera Wouhib Steven Zalcman Julia Zehr |
Others Present Virtually:
Deborah Krat, Webinar Support
Susan Funk, Webinar Support
Jerome Battle, NIH Videocast Specialist
Joy Jackson Farrar, NIH Videocast Specialist
Bob Hamer, NIH Videocast Specialist
Fran Kerrigan, NIH Videocast Specialist
| Appendix C | ||
| Staff Present Virtually for Closed Session: | ||
Evon Abisaid Mary Acri Lisa Alberts Susannah Allison Ruben Alvarez Phyllis Ampofo Patricia Areán Paige Anderson Victoria Arango Shelli Avenevoli Frank Avenilla Brian Barnett Anita Bechtholt Andrea Beckel-Mitchener Iddil Bekirov Yvonne Bennett Lora Bingaman Christina Borba Susan Borja Jasenka Borzan Beth Bowers Linda Brady Andrew Breeden Pim Brouwers Sandy Buckingham Marcy Burstein Holly Campbell-Rosen Mindy Chai Sharon Chang Zieta Charles Mark Chavez Eric Choi Serena Chu Jessenia Clary Heather Coulter Didi Cross Leonardo Cubillos Bruce Cuthbert Debra Dabney Beshaun Davis Julius Diggs Jen Donahue Jamie Driscoll Sabiha Ethridge Gregory Farber Jelena Fay-Lukic Katrina Ferrara Beth Finch Craig Fisher Jansen Foster Meredith Fox Mike Freed Stacia Friedman-Hill Nick Gaiano Karen Gavin-Evans | Rebecca Garcia Marjorie Garvey Lisa Gilotty Christopher Gordon Gregory Greenwood Adam Haim Katie Hamill Wanda Harris-Lewis Brittany Haynes Robert Heinssen Lauren Hill Mi Hillefors Shuang-Bao Hu Jennifer Humensky Eliza Jacobs-Brichford Daniel Janes Terri Jarosik Brittany Johnson Andrew W. Jones Jeymohan Joseph Eugene Kane Chris Kees Eunyoung Kim Megan Kinnane Sandeep Kishore Arina Knowlton Susan Koester Charisee Lamar Sarah Leinwand David Leitman Tamara Lewis Johnson Jane Lin Ti Lin Kelly Linthicum Sarah Holly Lisanby Allen Lo Victor Lushin Tianlu Ma Annette Marrero-Oliveras Nicole Martino Julie Mason Kristina Max Juliette McClendon Douglas Meinecke Tatiana Meza-Cervera Enrique Michelotti Nicole Miko David Miller Ashley Moseley Eric Murphy Laurie Nadler Stephen O’Connor Anna E. Ordóñez Nicolette O’Reilly Claudio Ortiz | Christina Page David Panchision Jenni Pacheco Emma Perez-Costas Courtney Pinard Suzy Pollard Amanda Price Vasudev Rao Dianne Rausch Sylvia Reeves Syed Rizvi Mary Rooney Andrew Rossi Laura Rowland Matthew Rudorfer Jonathan Sabbagh Christopher Sarampote Tanisha Savage Aileen Schulte Lori Scott-Sheldon Natasha Sefcovic Teri Senn Pamela Shell Joel Sherrill Lorie Shora Galia Siegel Todd Silber Belinda Sims Ashley Smith Dawn Smith Theresa Smith Abigail Soyombo Anaïs Stenson Michael Stirratt Maggie Sweeney Alexander Talkovsky Julie Thai Laura Thomas Ira Tigner, Jr. Jessica Tilghman Leonardo Tonelli Jing Tran Farris Tuma Justin Valenti Ashlee Van’t Veer Siavash Vaziri Vidya Vedham Aleksandra Vicentic Matthew Vilnit Clarissa B. Vincent Andrea Wijtenburg Kesi Williams Abera Wouhib Steven Zalcman Julia Zehr |
References
1Ben-Zion Z, Spiller TR, Keynan JN, Admon R, Levy I, Liberzon I, Shalev AY, Hendler T, Harpaz-Rotem I. Evaluating the Evidence for Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma. Am J Psychiatry. 2023 Feb 1;180(2):146-154. doi: 10.1176/appi.ajp.20220271. Epub 2023 Jan 11. PMID: 36628514; PMCID: PMC9898083.
2Gaudiano BA, Ellenberg S, Johnson JE, Mueser KT, Miller IW. Effectiveness of acceptance and commitment therapy for inpatients with psychosis: Implementation feasibility and acceptability from a pilot randomized controlled trial. Schizophr Res. 2023 Nov;261:72-79. doi: 10.1016/j.schres.2023.09.017. Epub 2023 Sep 14. PMID: 37716204; PMCID: PMC10841307.
3Yarur, H.E., Casello, S.M., Tsai, V.S. et al. Dynorphin / kappa-opioid receptor regulation of excitation-inhibition balance toggles afferent control of prefrontal cortical circuits in a pathway-specific manner. Mol Psychiatry (2023). https://doi.org/10.1038/s41380-023-02226-5